Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease.
about
The pathophysiology of thrombocytopenia in chronic liver diseaseSignal transduction of platelet-induced liver regeneration and decrease of liver fibrosisNew noninvasive index for predicting liver fibrosis in Asian patients with chronic viral hepatitis.The spleen in liver cirrhosis: revisiting an old enemy with novel targets.Erythropoietin increases platelet reactivity and platelet counts in patients with alcoholic liver cirrhosis: a randomized, double-blind, placebo-controlled study.The role of thrombopoietin in the thrombocytopenia of patients with liver cirrhosis.Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.[Platelet indices in chronic alcoholic liver disease patients with thrombocytopenia].Initial thrombocytopenia as a simple, valuable predictor for clinical manifestation in acute hepatitis A.Incidence, prevalence, and clinical significance of abnormal hematologic indices in compensated cirrhosis.Complete blood count, measures of iron status and inflammatory markers in inner-city African Americans with undiagnosed hepatitis C seropositivity.Pathobiology and treatment of hepatitis virus-related thrombocytopenia.Peripheral blood cytopaenia limiting initiation of treatment in chronic hepatitis C patients otherwise eligible for antiviral therapy.Preoperative use of romiplostim in thrombocytopenic patients with chronic hepatitis C and liver cirrhosis.Thrombocytopenia and bleeding in veterans with non-hepatitis C-related chronic liver disease.Eltrombopag: the discovery of a second generation thrombopoietin-receptor agonist.The role of eltrombopag in the management of hepatitis C virus-related thrombocytopenia.Partial splenic artery embolization in cirrhotic patientsImmunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational study.Hospital-acquired thrombocytopenia.β-Blocker therapy ameliorates hypersplenism due to portal hypertension in children.Determinants of platelet count are different in patients with compensated and decompensated cirrhosis.Comparative efficacy and cost effectiveness of splenectomy and thrombopoietin prior to peginterferon and ribavirin therapy with compensatory cirrhosis associated with hepatitis C and thrombocytopenia.Transient Elastography for Spleen Stiffness Measurement in Patients With Cirrhosis: Role in Degree of Thrombocytopenia.Thrombocytopenia in chronic liver disease.Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegalyPrognostic implication of liver histology in patients with nonalcoholic fatty liver disease in diabetesApoptotic bone marrow CD34+ cells in cirrhotic patients.Preoperative Aspartate Aminotransferase to White Blood Cell Count Ratio Predicting Postoperative Outcomes of Hepatocellular Carcinoma.Abnormal hematological indices in cirrhosis.Antiviral therapy in compensated and decompensated cirrhotic patients with chronic HCV infection.Big spleens and hypersplenism: fix it or forget it?Splenectomy increases the number of circulating hematopoietic stem/progenitor cells in patients with hepatitis C virus-associated liver cirrhosis.Can hypersplenism secondary to portal hypertension be treated by non-selective beta blockers?Venous thromboembolism in critically ill cirrhotic patients: practices of prophylaxis and incidence.Use of serum vitamin B12 level as a marker to differentiate idiopathic noncirrhotic intrahepatic portal hypertension from cryptogenic cirrhosis.Mini-nutritional assessment predicts functional status and quality of life of patients with hepatocellular carcinoma in Taiwan.[Role of splenectomy in the treatment of non-cirrhotic portal hypertension: about 3 cases].Quantitative Platelet Abnormalities in Patients With Hepatitis B Virus-Related Liver Disease.PRO-C3: a new and more precise collagen marker for liver fibrosis in patients with chronic hepatitis C.
P2860
Q26749277-92E8CF43-25B2-4D18-8968-A643019497CEQ27011588-1D018701-5B65-41C3-B627-84EF8B345791Q30354346-6E595C3C-67B4-4A59-8270-57DAD01F25EDQ30355782-EC83800F-0251-4055-A9FC-D33475CB7819Q33362054-FD79281B-F9D9-4EBB-ACAC-06AEDF514984Q33366601-13652723-CC96-4BAA-A4C1-4BF0F7D1A662Q33370831-A6CD0DC2-AFA6-4959-BF67-8DD446195C3DQ33377672-EBBDA337-18C8-4F7A-8343-637A96E9B5D6Q33381704-16A65F72-2925-496F-8888-07712D8B70EDQ33383677-C5CBC412-F0FC-443B-BE2B-5C1198D4FB65Q33388034-80F1C3C4-0653-4372-83AC-461F56D5EFFEQ33394547-EDA060CE-B2C7-473B-A133-F5991067DF18Q33400529-1E9C95B6-7118-4F4A-962E-D43031DAF712Q33402611-BC75B498-176D-4E07-958C-1DD9A2756D91Q33403528-EAB546C6-2369-4CE3-8A48-BF7929B49A94Q33406379-F50D2386-4A78-4880-BD0C-B45BCB7EEFCEQ33414386-814AB672-AD12-4E13-A074-6067A09C7268Q33415606-E56A55C4-951B-41BB-9DFE-422BCCC3C607Q33418708-E58135AE-5B58-4DBB-89EB-C18C805AED9FQ33419312-A2321F0B-BEF4-4906-ACFF-F13F5FB5099FQ33421297-BFA52830-966B-449D-8827-44F249D16B25Q33424074-E2899212-26C0-48AF-8A29-F7F30A28F8B8Q33428399-A1EB79AC-86B7-4B1A-89BC-FA80C6FB1EEFQ33433589-4EB504A5-DF7C-4720-B6A4-17619D5F0A95Q33436905-A9F5CBDD-7A6D-4F65-A9AB-53EA4F155177Q33440201-7FB5A85A-7125-425F-BB73-CA84B8E069DCQ34205386-84EC814F-E4C7-49A6-BE40-C2F03FF1C84DQ34863446-4D877585-7C54-43DB-8BE7-734D7E3B284FQ37206870-95372B9C-B5B0-42A8-A6CF-21EC803AF6FBQ37291711-B8D7F699-6525-46AE-B17B-3612806CDDBCQ37534731-08C70CD8-4489-47BA-B591-B9F3D34CF26CQ38259960-E4B281A2-98FF-4A95-B4F6-5F57EEE32BE6Q42232740-C17FC70E-FDFC-4AF6-93DE-BD0726303285Q42388703-B014E135-E6E1-4200-8F20-4F5E8341C490Q42776589-E5CB6D7C-2E85-4F56-9A55-5BF37DEFB13FQ43451124-6DECAF33-89D3-4727-B24D-D443FA272C8DQ44961078-35D3D5E8-D1FE-493C-B0A9-4B31D32E9592Q47118770-CC20ECF0-EDE4-40E5-8179-9FAEB41310D9Q47142999-3DE59790-4691-4051-8687-8FC5C816A1BDQ47600533-410177C1-B499-4352-AEBB-F627EE52E8DC
P2860
Prevalence of peripheral blood cytopenias (hypersplenism) in patients with nonalcoholic chronic liver disease.
description
2000 nî lūn-bûn
@nan
2000 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Prevalence of peripheral blood ...... coholic chronic liver disease.
@ast
Prevalence of peripheral blood ...... coholic chronic liver disease.
@en
Prevalence of peripheral blood cytopenias
@nl
type
label
Prevalence of peripheral blood ...... coholic chronic liver disease.
@ast
Prevalence of peripheral blood ...... coholic chronic liver disease.
@en
Prevalence of peripheral blood cytopenias
@nl
prefLabel
Prevalence of peripheral blood ...... coholic chronic liver disease.
@ast
Prevalence of peripheral blood ...... coholic chronic liver disease.
@en
Prevalence of peripheral blood cytopenias
@nl
P2093
P1476
Prevalence of peripheral blood ...... coholic chronic liver disease.
@en
P2093
P304
P356
10.1111/J.1572-0241.2000.02325.X
P407
P577
2000-10-01T00:00:00Z